PHASE I STUDY OF THE TRIPLE COMBINATION OF UFT/LEUCOVORIN, OXALIPLATIN AND IRINOTECAN IN PATIENTS WITH METASTATIC COLORECTAL CANCER

被引：0
|
作者：
Marsili, Stefania [1 ]
Petrioli, Roberto [1 ]
Sabatino, Marianna [1 ]
Paolelli, Loretta [1 ]
Sciandivasci, Angela [1 ]
Pascucci, Alessandra [1 ]
Ciliberto, Domenico [1 ]
Bindi, Mirco [1 ]
Correale, Pierpaolo [1 ]
Francini, Guido [1 ]
机构：
[1] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [41] A Phase II study of ANGIOZYME® in combination with 5-fluorouracil, leucovorin and irinotecan in the treatment of metastatic colorectal cancer patients
    Usman, N
    Venook, A
    Hurwitz, H
    Cunningham, C
    Fuchs, C
    Burris, H
    Schwartzberg, L
    Pelley, R
    Miller, WH
    Modiano, M
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S72 - S72
  • [42] IRINOTECAN, FLUOROURACIL AND LEUCOVORIN IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Davidov, Deyan
    JOURNAL OF IMAB, 2008, 14 (01): : 48 - 50
  • [43] Phase I/II study of irinotecan, 5-fluorouracil, and I-leucovorin combination therapy (modified Saltz regimen) in patients with metastatic colorectal cancer
    Goto A.
    Yamada Y.
    Hosokawa A.
    Ura T.
    Arai T.
    Hamaguchi T.
    Muro K.
    Shimada Y.
    Shirao K.
    International Journal of Clinical Oncology, 2004, 9 (5) : 364 - 368
  • [44] Phase I/II study of irinotecan, UFT, and leucovorin with hepatic arterial infusion in colorectal cancer patients with unresectable liver metastases: Preliminary results
    Yamaguchi, T.
    Matsumoto, H.
    Takahashi, K.
    Yasutome, M.
    Mori, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [45] An EORTC phase I study of Bortezomib in combination with oxaliplatin, leucovorin and 5-fluorouracil in patients with advanced colorectal cancer
    Caponigro, F.
    Lacombe, D.
    Twelves, C.
    Bauer, J.
    Govaerts, A. -S.
    Marreaub, S.
    Milano, A.
    Anthoney, A.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 48 - 55
  • [46] Phase I/II study of weekly paclitaxel (P), UFT and leucovorin in patients with metastatic breast cancer
    Chang, AY
    Beith, J
    Yeo, W
    Boyer, M
    Wong, J
    Lim, SE
    Chan, AT
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 59S - 59S
  • [47] A Phase I Study of Irinotecan, Capecitabine (Xeloda), and Oxaliplatin in Patients With Advanced Colorectal Cancer
    Maroun, Jean
    Marginean, Horia
    Jonker, Derek
    Cripps, Christine
    Goel, Rakesh
    Asmis, Timothy
    Goodwin, Rachel
    Chiritescu, Gabriela
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E257 - E268
  • [48] A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer
    Hoff, P. M.
    Kopetz, S.
    Thomas, M. B.
    Langleben, A.
    Rinaldi, D.
    Anthony, L.
    Wolff, R. A.
    Lassere, Y.
    Abbruzzese, J. L.
    BRITISH JOURNAL OF CANCER, 2008, 99 (05) : 722 - 726
  • [49] A phase II study of UFT with leucovorin administered as a twice daily schedule in the treatment of patients with metastatic colorectal cancer
    P M Hoff
    S Kopetz
    M B Thomas
    A Langleben
    D Rinaldi
    L Anthony
    R A Wolff
    Y Lassere
    J L Abbruzzese
    British Journal of Cancer, 2008, 99 : 722 - 726
  • [50] Phase I/II study of 24-hour infusion of irinotecan (CPT-11) in combination with sequential oral leucovorin (LV) and uracil/tegafur (UFT) for patients (PTS) with metastatic colorectal cancer (MCRC)
    Sadahiro, Sotaro
    Maeda, Yuji
    Suzuki, Toshiyuki
    Makuuchi, Hiroyasu
    Kamijo, Akemi
    Murayama, Chieko
    ANNALS OF ONCOLOGY, 2006, 17 : 117 - 117
12345